What is ELAN's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 11.20B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ELAN?

P/E (TTM) is n/a and 52-week range is $19.40 to $27.98 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ELAN figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ELAN?

The company profile lists revenue (TTM) near $4.96B, net income (TTM) near $-19.63B, EPS (TTM) near $-0.42 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Elanco Animal Health Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Indianapolis, Indiana, US, 499.4M shares outstanding, ISIN US28414H1032 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Elanco Animal Health Inc

$ELAN

Health Care · Pharmaceuticals

IR Run Scenarios

$22.41

-0.66%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Indianapolis, Indiana and currently employs 9,400 full-time employees. The company went IPO on 2018-09-20. The firm is engaged in delivering products and services to prevent and treat disease in farm animals and pets. The company serves animals across species, including dogs, cats, cattle, poultry, swine and sheep. Its pet health products help pets live longer, healthier and more active lives. Its pet health portfolio is focused on parasiticides, dermatology, vaccines and pain/other therapeutics. The company includes parasiticide portfolios in the pet health market based on indications, species and formulations, with products that protect pets from fleas, ticks and internal parasites. The company offers Advantage, K-9 Advantix, Advocate, and AdTab, which are over-the-counter treatments for the prevention and elimination of fleas and ticks. Its farm animal products help producers improve animal health and wellbeing. The company offers a farm animal portfolio of products for cattle including beef and dairy, poultry, swine and sheep.

Employees

9,400

Website

www.elanco.com/

IPO

2018-09-20

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)